Ep. 06 – Tirzepatide como tendência no tratamento para DM2. Episode 6
Monday, 17 May, 2021
Dual GIP and GLP-1 Receptor Agonist - Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.
(DOI: https://doi.org/10.1210/clinem/dgaa863)
We also recommend:
Gynecologic Oncology Update
Dr. Neil Love
Medicine and Imaging
Roberto Mogami
NeuroFreaky
NeuroFreaky
Círculo Benavides Podcast
Farmacias Benavides
MEP Mondays
SannahBanannah
Compliance Solved
healthcarecompliancepros
Gold Ribbon Conversations
Childhood Cancer Foundation Ireland
Omurilik yaralanmas sonras ürolojik ve cinsel problemler.Part II-Sayn Ürolog Özer Ural Çakc ile
Beyin Cerrahi Radyosu
